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ABSTRACT 
Numerous zinc ectoenzymes are 
metalated by zinc and activated in the 
compartments of the early secretory pathway 
before reaching their destination. Zn 
transporter (ZNT) proteins located in these 
compartments are essential for ectoenzyme 
activation. We have previously reported that 
ZNT proteins, specifically ZNT5–ZNT6 
heterodimers and ZNT7 homodimers, play 
critical roles in the activation of zinc 
ectoenzymes such as alkaline phosphatases 
(ALPs) by mobilizing cytosolic zinc into these 
compartments. However, this process remains 
incompletely understood. Here, using 
genetically engineered chicken DT40 cells, 
we first determined that Zrt/Irt-like protein 
(ZIP) transporters that are localized to the 
compartments of the early secretory pathway 
play only a minor role in the ALP activation 
process. These transporters included ZIP7, 
ZIP9, and ZIP13, performing pivotal 
functions in maintaining cellular homeostasis 
by effluxing zinc out of the compartments, 
Next, using purified ALP proteins, we showed 
that zinc metalation on ALP produced in 
DT40 cells lacking ZNT5–ZNT6 
heterodimers and ZNT7 homodimers is 
impaired. Lastly, by genetically disrupting 
both ZNT5 and ZNT7 in human HAP1 cells, 
we directly demonstrated that the tissue-
nonspecific ALP (TNAP)-activating functions 
of both ZNT complexes are conserved in 
human cells. Furthermore, using mutant 
HAP1 cells, we uncovered a previously 
unrecognized and unique spatial regulation of 
ZNT5–ZNT6 heterodimer formation, wherein 
ZNT5 recruits ZNT6 to the Golgi apparatus to 
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form the heterodimeric complex. These 
findings fill in major gaps in our 
understanding of the molecular mechanisms 
underlying zinc ectoenzyme activation in the 
compartments of the early secretory pathway. 
Zn transporter (ZNT)-family 
proteins except ZNT1 and ZNT10 (1-3) 
localize to specific subcellular compartments 
and perform unique functions (4,5). ZNT2, 
ZNT3, and ZNT8, which localize to 
regulatory secretory vesicles/granules in 
specialized cells, play pivotal roles in the 
specific physiological functions of these cells 
(6-13) in distinct manners (14-16); conversely, 
ZNT5, ZNT6, and ZNT7, which localize to 
the compartments of the early secretory 
pathway in generic cells, play general but key 
roles in the cells (17-19). One of these roles of 
ZNT proteins is their critical function of 
supplying zinc to numerous proteins, 
including several secretory, extracellularly 
membrane-bound or organelle-resident 
enzymes biosynthesized in the compartments 
(hereafter zinc ectoenzymes), for their 
activation (20,21). In this context, we have 
shown that vertebrate ZNT5-ZNT6 
heterodimers and ZNT7 homodimers are 
required for the activation of alkaline 
phosphatases (ALPs), such as tissue 
nonspecific ALP (TNAP) (22) and placental 
ALP (PLAP) (23), and several other 
ectoenzymes by using genetically engineered 
chicken DT40 cell mutants (24-27). 
In comparison to the elucidation of 
the importance of ZNT proteins in zinc 
ectoenzyme activation, the involvement of 
another family of zinc transporter proteins, 
Zrt/Irt-like proteins (ZIPs), in the activation 
remains less well studied (20,21). However, 
certain ZIPs have recently been clearly shown 
to play several pivotal roles in early secretory 
pathway functions (28-31). Specifically, ZIP7, 
ZIP9, and ZIP13 participate in zinc 
mobilization from the luminal side to the 
cytosol and contribute to the homeostatic 
maintenance of early secretory pathway 
functions, including those of the ER and Golgi 
apparatus (29,30,32-34), in addition to 
performing crucial functions in zinc signaling 
by regulating signal transduction pathways in 
response to various stimuli (35-38). These 
critical functions of ZIPs suggest that these 
proteins might contribute to the process 
underlying the activation of zinc ectoenzymes, 
including ALPs. 
The ability of ZNT5-ZNT6 
heterodimers and ZNT7 homodimers to 
activate TNAP has been shown to be 
conserved in other species, such as 
Caenorhabditis elegans (in which ZNT5 and 
ZNT6 are named Cdf5 and Toc1, 
respectively) (39), by using the DT40 cell 
system. However, we have not yet obtained 
direct evidence indicating that human cells 
lacking both ZNT complexes show similar 
defects in ALP activation as in the case of 
DT40 cells. In this study, we investigated this 
fundamental question and other related 
questions by performing various biochemical 
experiments on chicken DT40 cells and 
human HAP1 cells. Addressing these 
questions can deepen our understanding of the 
activation process of zinc ectoenzymes in the 
compartments of the early secretory pathway. 
Results 
Alteration of ZIP expression does not 
markedly affect Tnap activation. 
To examine how ZIPs localized to 
the early secretory pathway contribute to the 
TNAP activation process, we established 
DT40 cells deficient in zip13 (zip13-/-) or both 
zip9 and zip13 (zip9-/-zip13-/-) (Fig. S1). This 
is because we already established zip9-/- cells 
in our previous study (33), in which zip13 
mRNA expression was increased (Fig. 1A). 
The ortholog of ZIP7, another ZIP localized to 
the early secretory pathway, is not encoded by 
the chicken genome (40), which precluded the 
establishment of DT40 cells deficient in Zip7. 
3 
Tnap activity in zip9-/-, zip13-/-, and zip9-/-
zip13-/- cells was not markedly decreased (Fig. 
1A), and in zinc-deficient cultures, Tnap 
activity in zip9-/-zip13-/- cells, as in WT cells, 
was almost eliminated (Fig. 1B). Re-
expression of ZIP9 or ZIP13 in zip9-/-zip13-/- 
cells also did not alter Tnap activity as 
compared with the activity in WT and in zip9-
/-zip13-/- cells (Fig. 1C). To comprehensively 
investigate the functions of Zip9 and Zip13 in 
Tnap activation, we disrupted both 
metallothionein I and II (mtI and mtII, 
hereafter mt) in zip9-/-zip13-/- cells, and thus 
generated mt-/-zip9-/-zip13-/- cells; we did this 
because metallothioneins can chelate 
cytosolic zinc (41,42), and mt disruption in 
cells could thus drastically alter cellular zinc 
homeostasis. However, we found that Tnap 
activity in mt-/-zip9-/-zip13-/- cells was not 
altered relative to that in WT cells and zip9-/-
zip13-/- cells (Fig. 1D). 
ZIP7 has recently been reported to 
play a key role in zinc mobilization from the 
lumen of the ER (29-31), and the zinc-
transport activity of ZIP7 has further been 
reported to be facilitated by its 
phosphorylation by CK2 (37). To examine 
ZIP7 involvement in Tnap activation, we 
ectopically expressed WT ZIP7 or mutant 
ZIP7, either the phosphoablative form or the 
phosphomimetic active form (ZIP7S275A/S276A or 
ZIP7S275D/S276D) (37,43), in zip9
-/-zip13-/- cells 
(Fig. 1E). Expression of neither WT ZIP7 nor 
ZIP7S275A/S276A markedly altered Tnap activity 
in zip9-/-zip13-/- cells, whereas the expression 
of ZIP7S275D/S276D decreased Tnap activity by 
~40% (Fig. 1E). Moreover, zinc 
supplementation did not produce any changes 
in Tnap activity here (Fig. 1F), which 
excluded the possibility that ZIP7S275D/S276D 
expression decreased zinc levels in the lumen 
of the compartments of the early secretory 
pathway; this suggests that ZIP7S275D/S276D 
expression exerted its effect independently of 
the zinc-mobilization ability of the protein. 
We next examined whether 
disruption of both zip9 and zip13 in znt5-znt6-
/-znt7-/- (triple knockout; TKO) cells altered 
their reduced Tnap activity phenotype. DT40 
cells deficient in all of these genes, i.e., 
deficient in znt5, znt6, znt7, zip9, and zip13 
(TKOzip9-/-zip13-/- cells), showed drastically 
diminished Tnap activity much like TKO cells 
(Fig. 2A). Co-expression of ZNT5 and ZNT6 
or re-expression of ZNT7 in TKOzip9-/-zip13-
/- cells reversed this loss of Tnap activity (Fig. 
2B). Moreover, time-course experiments 
revealed the distinct contributions of ZIP and 
ZNT proteins to Tnap activation; from 
measurements of Tnap activity, the 
absorbance at 405 nm in both TKO cells and 
TKOzip9-/-zip13-/- cells was found not to be 
saturated for up to 240 min, whereas that in 
zip9-/-zip13-/- cells, TKOzip9-/-zip13-/- cells 
stably co-expressing ZNT5 and ZNT6, and 
TKOzip9-/-zip13-/- cells stably expressing 
ZNT7 was saturated by 120 min. This 
suggests that Tnap activity was drastically 
decreased in cells lacking Znt proteins as 
compared with that in Zip-deficient cells (Fig. 
2C). These results clearly confirmed that 
ZNT5-ZNT6 heterodimers and ZNT7 
homodimers play indispensable roles in 
TNAP activation, but that ZIPs, such as ZIP9 
and ZIP13, play only minor roles. 
Plant ZNT5-ZNT6 orthologs can activate 
Tnap. 
We previously showed that the 
function of ZNT5-ZNT6 heterodimers in 
Tnap activation is conserved in nematode 
orthologs by using the TKO cells (39). The 
conservation of this key function was further 
examined by expressing plant ZNT5 and 
ZNT6 orthologs, Mtp12 and Mtp5, in TKO 
cells. The results of co-immunoprecipitation 
experiments showed functional interaction 
between Mtp12 and Mtp5 and between Mtp12 
and a splicing variant of Mtp5 (svMtp5, 
named Mtp5t2 in a previous study (44)) in 
TKO cells (Fig. 3A). Tnap activity was 
restored only following the co-expression of 
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hemagglutinin (HA)- or FLAG-tagged Mtp12 
and Mtp5 (Fig. 3B), as expected from the 
results of the previous zinc-transport study 
(44), and both of these proteins were 
colocalized in the Golgi apparatus in TKO 
cells (Fig. 3C). Notably, this restoration of 
Tnap activity was abolished following the 
replacement of histidine or aspartic acid with 
alanine in the putative transmembranous zinc-
binding site of Mtp12 (Mtp12H452A and 
Mtp12D666A), which probably generates loss-
of-function mutants (Fig. 3D). Moreover, the 
restoration of Tnap activity by Mtp12-Mtp5 
heterodimers was partial as compared with 
that mediated by ZNT5-ZNT6 co-expression, 
even when untagged Mtp12 and Mtp5 were 
used (Fig. 3E); this might reflect the effect of 
a single Pro residue in the PP-motif in luminal 
loop 2 of Mtp12, because the loss of one Pro 
residue in ZNT5 leads to reduced ability for 
Tnap activation (39). These results indicate 
that the Tnap-activation ability is highly 
conserved in ZNT5-ZNT6 orthologs, 
including those from plants, although the plant 
orthologs are relatively less effective in Tnap 
activation. 
ZNT5-ZNT6 heterodimers and ZNT7 
homodimers are required for proper zinc 
metalation of ALPs. 
ZNT5-ZNT6 heterodimers and 
ZNT7 homodimers play essential roles in 
TNAP activation; however, how TNAP 
protein is affected when expressed in the TKO 
cells was unclear. We addressed this question 
by using PLAP, an isozyme of TNAP, as a 
model, because we found that the secreted 
form of PLAP (secPLAP), which lacks the 
glycosylphosphatidylinositol (GPI) anchor 
(45), was not degraded when stably expressed 
in TKO cells (Fig. 4A and B). By contrast, 
PLAP, when stably expressed in TKO cells, 
was degraded through cellular lysosomal and 
proteasomal degradation pathways (Fig. 4C-
E) similarly as TNAP (25). The ZNT-
complex-dependence of PLAP activity was 
not noticeably altered between secPLAP and 
PLAP when expressed in TKO cells (Fig. 4B 
and D), which indicates that secPLAP is likely 
present in an apo-form in TKO cells. Thus, we 
stably expressed C-terminally HA-tagged 
secPLAP (secPLAP-HA) (46) in WT and 
TKO cells (Fig. 4F), and purified the protein 
from both cells by using anti-HA-tag antibody 
(see Materials and Methods) (Fig. S2). The 
activity of secPLAP-HA purified from TKO 
cells was substantially lower than that of the 
protein from WT cells (Fig. 4G), which agrees 
with the activity measured before purification 
(Fig. 4F). ICP-MS analysis revealed that the 
relative zinc content in secPLAP-HA purified 
from TKO cells was drastically lower than 
that in the protein purified from WT cells (Fig. 
4H), suggesting that zinc metalation of 
secPLAP-HA was impaired in TKO cells. 
Furthermore, ALP zymography and 
immunoblotting performed using native-
PAGE gels failed to reveal the activity or the 
protein of secPLAP-HA purified from TKO 
cells at the corresponding positions as those of 
the protein from WT cells (Fig. 4I), although 
the proteins were detected at the same 
positions when immunoblotting was 
performed after SDS-PAGE (Fig. 4A and B); 
this indicates that secPLAP-HA purified from 
TKO cells might not be properly folded. These 
results clearly show that by supplying zinc to 
ALPs such as PLAP, ZNT5-ZNT6 
heterodimers and ZNT7 homodimers play 
indispensable roles in the expression of ALP 
activity. 
Conserved TNAP-activation functions of 
ZNT5-ZNT6 heterodimers and ZNT7 
homodimers in human cells. 
We have shown that ZNT5-ZNT6 
heterodimers and ZNT7 homodimers are 
indispensable for the activation of several zinc 
ectoenzymes, including TNAP and PLAP, by 
using genetically engineered chicken DT40 
cells (24-27). However, a fundamental 
question that has remained unanswered is 
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whether this holds true for mammalian cells, 
including human cells. We addressed this 
question by establishing cultured human cells 
lacking ZNT5-ZNT6 heterodimers and ZNT7 
homodimers: we disrupted ZNT5 and/or ZNT7 
by using the CRISPR/Cas9 system, and we 
used HAP1 cells for these studies because 
these cells exhibit zinc-dependent TNAP 
activity (Fig. 5A) (27) in addition to their 
unique haploid phenotype. TNAP activity was 
not substantially decreased in ZNT5 or ZNT7 
KO HAP1 cells (HAP-Z5-KO or HAP-Z7-KO 
cells) (Fig. 5B, Fig. S3), unlike in the case of 
DT40 cells, in which the activity was 
decreased by 45%–60% and 20%–30%, 
respectively, after Znt5 and Znt7 KO (24,47). 
However, in ZNT5 and ZNT7 double KO cells 
(HAP-Z5Z7-DKO cells), TNAP activity was 
markedly decreased together with a decrease 
in protein expression (Fig. 5B), as in the case 
of DT40 cells lacking both Znt5 and Znt7 and 
in the TKO cells (24,47). We confirmed this 
requirement of the disruption of both ZNT5 
and ZNT7 for decreasing TNAP activity by 
using differently generated HAP1 cells 
deficient in ZNT5 and/or ZNT7 (HAP-Z7-
KO(new) and HAP-Z5Z7-DKO(new)) (Fig. 5C, 
Fig. S1). Immunofluorescence staining 
revealed the loss of TNAP cell-surface 
localization in HAP-Z5Z7-DKO cells (Fig. 
5D), which was also confirmed by the results 
of cell-surface biotinylation assays (Fig. 5E). 
TNAP was degraded through both the 
lysosomal and the proteasomal degradation 
pathways in HAP-Z5Z7-DKO cells, because 
the decreased TNAP protein expression in 
HAP-Z5Z7-DKO cells was partially restored 
(in terms of both the glycosylated size and the 
immature size) when cultured in the presence 
of lysosomal and proteasomal inhibitors (Fig. 
5F). Moreover, we confirmed that ZNT5 and 
ZNT7 were essential for zinc ectoenzyme 
activation by stably overexpressing TNAP 
and PLAP. As expected, overexpressed TNAP 
and PLAP exhibited little activation in HAP-
Z5Z7-DKO cells as compared with the 
enzymes expressed in WT HAP1 cells (Fig. 
5G and H). Accompanying this marked 
reduction in activity, TNAP and PLAP protein 
expression in HAP-Z5Z7-DKO cells was 
undetectable in immunoblotting assays (Fig. 
5G and H, lane 5), although both proteins 
were detected in WT cells even when cultured 
under zinc-deficient conditions (Fig. 5G and 
H, lane 3); this is in accord with our present 
and previous results obtained using DT40 cell 
systems (27,48). 
The decrease in activity and loss of 
protein expression of TNAP were reversed by 
re-expression of ZNT5 or ZNT7 (Fig. 6A). 
Besides the re-expression of these human 
proteins, re-expression of the chicken 
orthologs in HAP-Z5Z7-DKO cells also 
restored TNAP activity and protein expression 
(Fig. 6B), which indicates complete 
compatibility between the human and chicken 
cellular systems in terms of TNAP activation 
by ZNT proteins. Concomitantly with this 
restoration, re-expression of ZNT5 or ZNT7 
also fully rescued the cell-surface expression 
of TNAP (Fig. 6C and D). However, TNAP 
activity was not restored by zinc 
supplementation in the culture medium of 
HAP-Z5Z7-DKO cells (Fig. 6E), nor by stable 
expression of the zinc-transport-incompetent 
ZNT5H451A mutant (Fig. 6F). These results 
indicate that ZNT5-ZNT6 heterodimers and 
ZNT7 homodimers cooperatively play critical 
roles in TNAP activation by supplying zinc in 
human HAP1 cells, as in the case of chicken 
DT40 cells, although the effect produced by 
singly disrupting ZNT5 or ZNT7 in HAP1 
cells appeared to differ slightly from that in 
DT40 cells. 
ZNT5 uniquely recruits ZNT6 to Golgi 
apparatus by forming ZNT5-ZNT6 
heterodimers. 
ZNT5 and ZNT6 have been widely 
demonstrated to form heterodimers and 
localize to the Golgi apparatus (47,49,50). 
However, the molecular features of ZNT5 and 
6 
ZNT6 heterodimer formation have remained 
largely unknown thus far. ZNT6 expression 
levels were constant in HAP-Z5Z7-DKO cells 
regardless of the presence or absence of ZNT5 
expression (Fig. 7B). Intriguingly, 
immunofluorescence staining revealed that 
ZNT6 was localized to the Golgi apparatus in 
WT HAP1 cells but not HAP-Z5Z7-DKO 
cells (Fig. 7C), and ZNT6 was thus found to 
be dispersed in the DKO cells (Fig. 7C, first 
and second columns). Re-expression of ZNT5 
in HAP-Z5Z7-DKO cells restored the Golgi 
localization of ZNT6 (Fig. 7C, third column) 
together with that of the re-expressed ZNT5 
(Fig. 7D, second column). Moreover, this 
trafficking of ZNT6 to the Golgi by ZNT5 was 
found to be independent of the zinc-transport 
activity of ZNT5, because the same effect was 
produced by the zinc-transport-incompetent 
ZNT5H451A mutant (Fig. 7D, third column). 
We also confirmed that ZNT7 re-expression in 
HAP-Z5Z7-DKO cells did not affect ZNT6 
localization: ZNT6 remained dispersed in the 
cells despite ZNT7 itself being localized to the 
Golgi apparatus (Fig. 7E). The dependence of 
ZNT6 localization on ZNT5 was also 
confirmed in HAP-Z5-KO cells (Fig. S4), 
where ZNT6 was dispersed in the cells, much 
as in HAP-Z5Z7-DKO cells. These results 
indicate that ZNT5 recruits ZNT6 to the Golgi 
apparatus to form the functional ZNT5-ZNT6 
heterodimers that are required for activating 
zinc ectoenzymes such as TNAP. 
Discussion 
A fundamental but notable 
contribution of this study is that it clearly 
confirmed that the TNAP-activation functions 
of ZNT5-ZNT6 heterodimers and ZNT7 
homodimers are highly conserved in 
eukaryotes, including plants. Specifically, our 
study revealed that human HAP1 cells lacking 
both of these ZNT complexes lost TNAP 
activity as in the case of chicken DT40 cells, 
and that this was reversed by the expression of 
human ZNTs and chicken ZNT orthologs in 
the cells. We previously showed that the 
reduced TNAP activity in TKO DT40 cells 
was reversed by both human ZNTs and 
chicken ZNT orthologs (24,47), which 
indicated that the functions of ZNT complexes 
in the TNAP activation process are compatible 
between human and chicken. Intriguingly, 
however, TNAP activity exhibited certain 
differences when only one of the complexes 
was expressed in the cells: whereas TNAP 
activity was almost the same in WT HAP1 
cells and HAP-Z5-KO or HAP-Z7-KO cells, 
Tnap activity relative to WT was decreased to 
45%–60% in znt5- DT40 cells and 20%–30% 
in znt7-/- DT40 cells (24,47). This 
phenomenon could be either species-specific 
or enzyme (TNAP)-specific, and to clarify this, 
it will be critical to characterize the properties 
of the respective ZNT complexes in human 
and chicken from the viewpoint of the activity 
of each zinc ectoenzyme. 
We have reported here a previously 
unrecognized unique property of ZNT5-ZNT6 
heterodimers. The Golgi localization of ZNT6 
observed in WT cells was lost in ZNT5-
deficient cells (HAP-Z5Z7-DKO and HAP-
Z5-KO cells), and this was restored following 
ZNT5 expression. Considering that ZNT6 
localizes to the Golgi apparatus in WT HAP1 
cells, in which ZNT6 forms heterodimers with 
ZNT5, the mechanism by which ZNT5 
recruits ZNT6 to the Golgi apparatus is 
probably involved in the general regulation of 
ZNT5-ZNT6 heterodimer formation; this 
makes it likely that ZNT5-ZNT6 heterodimers 
supply zinc to zinc ectoenzymes such as 
TNAP and PLAP in or around the Golgi 
apparatus. How might ZNT5-ZNT6 
heterodimers localize to the Golgi apparatus? 
One possibility is anterograde trafficking from 
the ER to the Golgi after heterodimerization in 
the ER, whereas another is retrograde 
trafficking from cytosolic vesicles, where 
ZNT6 is localized as a protomer, to the Golgi 
apparatus after heterodimerization in the 
vesicles. We have not yet determined the 
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precise subcellular localization of the ZNT6 
protomer in HAP-Z5Z7-DKO and HAP-Z5-
KO, and thus we cannot currently discriminate 
between these two possibilities. If ZNT5-
ZNT6 heterodimer formation is also spatially 
controlled in other vertebrates, this might 
represent one of the reasons why most 
vertebrates harbor two ZNT complexes for 
mobilizing zinc into the lumen of the 
compartments of the early secretory pathway: 
the availability of distinct regulatory 
mechanisms for controlling the expression of 
ZNT5-ZNT6 heterodimers and ZNT7 
homodimers could enable fine-tuning of zinc 
ectoenzyme activation. The genomes of 
certain eukaryotes code for only one of the 
ZNT transport complexes; for example, 
Saccharomyces cerevisiae, S. pombe, and C. 
elegans express only the ZNT5-ZNT6 
ortholog (51-54), whereas Drosophila 
melanogaster expresses only the ZNT7 
ortholog (40,55-57). In such cases, other ZNT 
proteins might provide another zinc-entry 
route in the early secretory pathway and thus 
allow the fine-tuning of enzyme activation; 
however, our previous study excluded this 
possibility in the case of vertebrates: 
overexpression of ZNT1, ZNT2, ZNT3, 
ZNT4, and ZNT8 failed to activate TNAP (25). 
A recent study in S. pombe supports the 
aforementioned possibility, because Zhf1 (a 
distant ZNT homolog) in the ER plays a role 
in activating yeast ALP Pho8 redundantly 
with the Cis4-Zrg17 (ZNT5-ZNT6 ortholog) 
pathway in the Golgi apparatus (58,59). 
Redundant zinc-entry routes in the early 
secretory pathway that are regulated in distinct 
manners would be necessary for appropriately 
activating numerous zinc-requiring protein 
functions during the life of an organism. 
Another critical finding of this 
study is that relative to the ZNT transport 
complexes, ZIP9, ZIP13, and ZIP7 are 
unlikely to contribute substantially to the 
regulation of zinc ectoenzyme activation. This 
was also our speculation in previous studies 
(25,33), but we clearly confirmed this here by 
using genetically engineered cells; Tnap 
activity in TKO cells and TKOzip9-/-zip13-/- 
cells was extremely low as compared with that 
in TKOzip9-/-zip13-/- cells re-expressing 
ZNT5-ZNT6 heterodimers or ZNT7 
homodimers (Fig. 2C). Given that ZIPs 
localized to the early secretory pathway have 
recently been widely reported to play crucial 
roles in the homeostasis of the early secretory 
pathway (29,30,32-34), our results suggest 
that ZNT5-ZNT6 heterodimers and ZNT7 
homodimers directly and specifically manage 
the zinc supply to the target ectoenzymes 
independently of ZIPs. 
We found that secPLAP-HA 
protein expressed in TKO cells was not 
detectable in either ALP zymography or 
immunoblotting performed using native-
PAGE gels, which could be because of the 
failure of secPLAP-HA to enter the native-
PAGE gels. Although the underlying reason 
remains to be determined, protein misfolding 
due to the loss of zinc metalation could be 
responsible. This might also explain why 
PLAP expressed in TKO cells was degraded 
through the cellular degradation pathway: the 
protein would have been misfolded because of 
impaired zinc metalation. Considering the 
differences between PLAP and secPLAP, the 
addition of the GPI anchor might facilitate the 
protein degradation, and addressing this 
question could provide information regarding 
the manner in which ZNT5-ZNT6 
heterodimers and ZNT7 homodimers 
contribute to homeostatic maintenance in the 
early secretory pathway (48,51). However, 
other possibilities also exist, such as 
homeostatic maintenance being achieved 
through the regulation of chaperone-protein 
functions by zinc that is mediated by both 
complexes (60,61). Disruption of Znt and/or 
Zip genes in DT40 cells and ZNT genes in 
HAP1 cells increased the mRNA expression 
of other Znt and/or Zip genes in DT40 cells 
and ZNT genes in HAP1 cells (Figs. 1A, 2A, 
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Fig. S3A). These results suggest that complex 
complementation mechanisms might act on 
the numerous zinc transporter proteins 
expressed in the early secretory pathway in 
vertebrate cells. As discussed above, the 
molecular mechanisms underlying these 
responses warrant further investigation. 
Our results here provide insights 
into the molecular mechanism by which zinc 
ectoenzymes such as TNAP and PLAP are 
activated, revealing clearly that ZNT5-ZNT6 
heterodimers and ZNT7 homodimers are 
indispensable for the activation process. 
However, our findings also raise several 
specific questions regarding the relationships 
between the “activity” and the 
“stability/degradation” of zinc ectoenzymes 
mediated by ZNT complexes: Why is it that 
secPLAP, the “GPI-deficient form,” was not 
degraded in cells (Fig. 4G), but PLAP was? 
Why was PLAP expressed in DT40 TKO cells 
degraded more markedly (Fig. 4C) than PLAP 
expressed in znt5-znt7-/- cells (24)? Why was 
TNAP not stabilized in HAP-Z5Z7-DKO cells 
stably expressing zinc-transport-incompetent 
ZNT5H451A mutant (Fig. 6E), but stabilized in 
DT40 TKO cells stably expressing the mutant 
(25)? In relation to this last question, why was 
TNAP not completely degraded in WT HAP1 
cells cultured under zinc-deficient conditions 
(Fig. 5A)? Answers to these questions will 
further enhance our understanding of the 
activation process of zinc ectoenzymes in the 
early secretory pathway. Novel approaches, 
including zinc-ome analysis, from a viewpoint 
of the relationships between “activity” and 
“stability/degradation” might be crucial for 
obtaining answers to these questions in future 
studies (62). 
In conclusion, we addressed 
certain unresolved questions regarding the 
activation of zinc ectoenzymes by ZNT5-
ZNT6 heterodimers and ZNT7 homodimers, 
and we 1) found that ZIPs make minor 
contributions to TNAP activation, 2) 
demonstrated that zinc metallation of PLAP 
produced in cells lacking both of the 
aforementioned ZNT complexes is impaired, 
and 3) confirmed that the function of the ZNT 
transport complexes in TNAP activation is 
highly conserved among eukaryotes. 
Furthermore, we uncovered a previously 
unknown unique mechanism regulating 
ZNT5-ZNT6 heterodimer formation, where 
ZNT5 recruits ZNT6 to the Golgi apparatus to 
form the heterodimers. As noted above, our 
results raise additional questions about the 
enzyme activation process; however, our 
findings also considerably enhance current 
understanding of the process by providing 
new molecular insights into how zinc 
ectoenzymes are activated by zinc in the 
compartments of the early secretory pathway. 
Experimental Procedures 
Plasmid construction—Plasmids for 
expressing epitope-tagged human ZIP13, 
ZIP9, and ZIP7 (both WT and mutants) were 
constructed by inserting each cDNA into pA-
Puro, pA-Zeocin, pA-Ecogpt, or pA-Neo 
vector (33,37). The expression vectors for 
Arabidopsis thaliana Mtp12 and Mtp5 were 
constructed by inserting each cDNA into pA-
Puro or pA-Ecogpt vector. FLAG- or HA-tag 
sequence was fused to respective genes by 
using a two-step PCR method, and the 
amplified cDNAs were sequenced in both 
directions. Mutations in Mtp12 expression 
plasmids (Mtp12H452A and Mtp12D666A) were 
also introduced using a two-step PCR method. 
The FLAG-, HA-, or Halo-tagged ZNT5 
and/or ZNT7 expression vectors used were 
described previously (27,49), as were the 
plasmids for expressing TNAP and PLAP 
(27,48). To construct secPLAP-HA 
expression plasmid, the encoding cDNA (46) 
was inserted into pA-Puro vector. To disrupt 
chicken zip13, the zip13 fragments were PCR-
amplified using gene-specific primers by 
using KOD-FX polymerase (TOYOBO, 
Osaka, Japan) with DT40 genomic DNA as a 
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template, and were then used for the long or 
short arms. The long or short arms were 
subcloned downstream or upstream of the 
drug-selection marker cassettes that included 
the drug-resistant genes (Bsr or HisD) flanked 
by mutant loxP sites (Fig. S1A). All plasmids 
were linearized using appropriate restriction 
enzymes before electroporation or lipofection. 
Cell culture—Chicken B lymphocyte-derived 
DT40 cells were maintained in RPMI 1640 
medium (Nacalai Tesque, Kyoto, Japan) 
supplemented with 10% (v/v) heat-inactivated 
fetal calf serum (FCS; Sigma, St. Louis, MO, 
USA), 1% (v/v) chicken serum (Invitrogen, 
Carlsbad, CA, USA), and 50 µM 2-
mercaptoethanol (Sigma) at 39.5 °C, as 
previously described (63). Human 
myelogenous leukemia HAP1 cells 
(purchased from Horizon Discovery, 
Cambridge, UK) were maintained in IMDM 
(Nacalai Tesque) containing 10% (v/v) heat-
inactivated FCS (Sigma) at 37 °C. In certain 
experiments, to inhibit protein degradation, 
DT40 mutant cells were treated for 4 h with 
100 µM MG132 (Peptide Institute, Osaka, 
Japan) or 100 nM bafilomycin A1 (Sigma) 
before collecting cells, or HAP1 mutant cells 
were cultured for 12 h in the presence of 10 
µM MG132, 10 nM bafilomycin A1, 20 mM 
NH4Cl, and 10 µM lactacystin (Peptide 
Institute, Osaka, Japan) before collecting cells. 
To generate zinc-deficient culture medium, 
FCS or chicken serum was treated with 
Chelex-100 resin (Bio-Rad Laboratories, 
Hercules, CA, USA) as described (64). For 
zinc-supplementation experiments, cell-
culture medium containing the indicated 
concentrations of ZnSO4 was added. 
Disruption of zip13 and/or zip9 in WT, zip9-/-, 
and TKO DT40 cells—WT or zip9-/- cells were 
transfected sequentially with zip13 targeting 
vectors (Fig. S1A) by electroporation to 
disrupt zip13. To establish TKOzip9-/-zip13-/- 
cells, TKO cells were transfected sequentially 
with zip9 and zip13 targeting vectors after 
excising the drug-selection marker cassettes 
by using 4-hydroxytamoxifen (Sigma) as 
described previously (63). Gene disruption 
was confirmed by means of genomic-DNA 
PCR or RT-PCR. Genomic DNA, which was 
prepared as described (63), was used as a 
template and PCR-amplified using KOD-FX 
(TOYOBO). The primers used for confirming 
zip13 disruption (Fig. S1A) are listed in Table 
S1. RT-PCR was performed using total RNA 
isolated from harvested cells by using Sepasol 
I (Nacalai Tesque) and reverse-transcribed 
using ReverTra Ace (TOYOBO). PCR was 
performed using KOD-FX. The primers used 
in RT-PCR are listed in Table S2. 
Electroporation was used to establish DT40 
disruptants. 
Disruption of ZNT5 and/or ZNT7 in HAP1 
cells—ZNT5 and/or ZNT7 gene disruption 
was performed through CRISPR/Cas9-
mediated genome editing. Oligonucleotides 
for generating sgRNA expression plasmids 
were annealed and cloned into the BbsI or 
BsaI site of PX-330-B/B vector (3). The 
following oligonucleotides were used: ZNT7-
152F: 5ʹ-
CACCTGGAACTACTCTACGGCATC-3ʹ, 
ZNT7-152R: 5ʹ-
AAACGATGCCGTAGAGTAGTTCCA-3ʹ; 
ZNT5-1510F: 5ʹ-
CACCGGCGTGCTGACCAATAGTCT-3ʹ, 
ZNT5-1510R: 5ʹ-
AAACAGACTATTGGTCAGCACGCC-3ʹ 
(guide RNA sequences are underlined). The 
constructed plasmids and one-tenth quantity 
of pcDNA6/TR (containing blasticidin S-
resistance gene) or pA-puro (containing 
puromycin-resistance gene) were co-
transfected into 80% confluent HAP1 cells by 
using Lipofectamine 2000 (Invitrogen). The 
cells were cultured for 1 day and transferred to 
a 10-cm cell culture dish and treated with 20 
µg/mL blasticidin (InvivoGen, San Diego, CA, 
USA) or 0.75 µg/mL puromycin (Sigma) to 
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establish stable clones. HAP1 cells deficient 
in ZNT5 and/or ZNT7 were confirmed by 
directly sequencing the fragments amplified 
using genomic-DNA PCR and RT-PCR; the 
primers used are shown in Table S3. ZNT7-
KO HAP1 (HAP-Z7-KO) cells were 
purchased from Horizon Discovery. 
Measurement of ALP activity—Membrane 
proteins or total-protein extracts from cells 
were prepared in ALP lysis buffer, and 3 or 5 
µg of membrane proteins or 5 µg of total 
proteins were used for measuring TNAP or 
PLAP activity as previously described (63). 
For measuring the activity of purified 
secPLAP-HA, we used the same amounts of 
protein estimated from SDS-PAGE band 
intensity. The released p-nitrophenol was 
quantified by measuring the 405-nm 
absorbance of assay samples. PLAP activity 
was measured after samples were treated at 
65 °C for 30 min. 
Immunoblotting—Immunoblotting was 
performed as described (65). Briefly, blotted 
PVDF membranes (Immobilon-P, Millipore 
Corp., Bedford, MA, USA) were blocked with 
5% skimmed milk/0.1% Tween-20 in PBS 
and then incubated with primary antibodies 
(diluted in blocking buffer): anti-FLAG M2 
(1:3000; F3165, Sigma), anti-HA HA-11 
(1:3000; MMS-101P, Covance, Emeryville, 
CA, USA), anti-HA clone 3F10 (1:3000; 
11867423001, Roche Applied Science, 
Mannheim, Baden-Württemberg, Germany), 
anti-Myc (1:3000; sc-40, Santa Cruz 
Biotechnology Inc., Santa Cruz, CA, USA), 
anti-TNAP (1:3000; sc-30203 and sc-166261, 
Santa Cruz Biotechnology), anti-PLAP 
(1:3000; sc-15065 (L-19) or sc-47691, Santa 
Cruz Biotechnology), anti-calnexin (1:6000; 
ADI-SPA-860, Enzo Life Sciences, 
Plymouth Meeting, PA, USA), anti-
calreticulin (1:5000; PA3-900, Affinity 
Bioreagents, Golden, CO, USA), anti-ZNT5 
(1:1000) (17), anti-ZNT6 (1:3000; 13526-1-
AP, Proteintech Group Inc., Chicago, IL, 
USA), or anti-α-tubulin (1:5000; 12G10, 
deposited to Developmental Studies 
Hybridoma Bank by J. Frankel and E.M. 
Nelsen). Immunoreactive bands were detected 
using 1:3000 horseradish peroxidase-
conjugated anti-mouse or anti-rabbit 
secondary antibodies (GE Healthcare, 
Milwaukee, WI, USA, NA931 or NA934) or 
anti-goat secondary antibody (sc-2020, Santa 
Cruz Biotechnology) and Immobilon Western 
Chemiluminescent HRP Substrates 
(Millipore) or SuperSignal West Femto 
Maximum Sensitivity Substrate (Pierce, 
Rockford, IL, USA). Fluoro-images were 
obtained using a LAS 500 (GE Healthcare). 
Cell-surface biotinylation assay—Cell-
surface biotinylation assay was performed as 
described (65). After washing cells with PBS, 
we added EZ-Link, a sulfo-NHS-SS-biotin 
reagent (Pierce Protein Biology, Thermo 
Fisher Scientific, Rockford, IL, USA). 
Subsequently, biotinylated proteins were 
captured using streptavidin-coupled beads and 
recovered in 6× SDS sample buffer and 
immunoblotted. 
Co-immunoprecipitation—Co-
immunoprecipitation was performed as 
described (24). Briefly, 200 µg of membrane 
proteins were prepared from DT40 cells stably 
expressing HA-Mtp12 and FLAG-Mtp5s after 
lysis in an NP-40 buffer containing 0.05% 
SDS, and proteins were then 
immunoprecipitated with monoclonal 
antibodies: anti-FLAG M2 (1:200) and anti-
HA (1:200; HA11) for DT40 cells. After 
rotating samples for 1 h, 15 µL of protein G-
Sepharose beads (GE Healthcare) were added, 
and the sample tubes were rotated again 
(overnight, at 4 °C). Subsequently, the 
samples were centrifuged at 15,000 rpm for 5 
min, and the pelleted beads containing the 
immunoprecipitates were washed thrice with 
the NP-40 buffer without SDS and eluted with 
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12.5 µL of 2× urea buffer and 2.5 µL of Ling’s 
solubilizing buffer. After incubation for 30 
min at room temperature, 13 µL of each 
supernatant was electrophoresed; 20 µg of 
membrane proteins that were not subject to 
co-immunoprecipitation were used as the 
input fraction. Immunoreactive bands were 
detected as described above. 
Immunofluorescence staining—
Immunostaining was performed as described 
(24,63) with these first antibodies: anti-FLAG 
(1:2000; anti-DDDDK; MBL, Nagoya, Japan), 
anti-HA (1:1000; HA11), anti-GM130 
(1:1000; 610823, BD Transduction 
Laboratories, Lexington, KY, USA), anti-
ZNT5 (1:500), anti-ZNT6 (1:500; 
HPA055032; Atlas Antibodies AB, 
Stockholm, Sweden), or anti-TNAP (1:500). 
The second and third antibodies used were 
Alexa 488-conjugated goat anti-rabbit IgG, 
rabbit anti-goat IgG, and goat anti-mouse IgG 
and Alexa 594-conjugated donkey anti-rabbit 
IgG (all from Molecular Probes, Eugene, OR, 
USA). The antibodies were applied at room 
temperature for 1 h or at 4 °C overnight, and 
4,6-diamino-2-phenylindole (DAPI) was 
added during second and third antibody 
staining to label nuclei. For staining TNAP, 
the second and third antibodies were diluted 
respectively with Can Get Signal Solution B 
and Can Get Signal Solution A (TOYOBO); 
otherwise, 2% BSA in PBS was used as the 
dilution buffer. The stained cells were 
examined using a fluorescence microscope 
(FSX100; Olympus, Tokyo, Japan) and 
images were analyzed using Adobe Photoshop 
CS. Identical exposure settings and times were 
used for the corresponding images in each 
figure. 
Purification of secPLAP-HA—DT40 WT or 
TKO cells stably expressing secPLAP-HA 
were collected and resuspended in 5 mL of 
cold homogenizing buffer (0.25 M sucrose, 20 
mM HEPES, 1 mM EDTA). After 
homogenization (30 strokes, 10×) in a 7-mL 
Dounce homogenizer on ice, homogenates 
were centrifuged at 2300 × g for 5 min at 4 °C, 
and the obtained post-nuclear supernatant was 
centrifuged at 15,000 × g for 30 min at 4 °C. 
The supernatant was collected as sup A. The 
pellet was lysed in lysis buffer (0.1% NP-40, 
50 mM HEPES, 100 mM NaCl, 1.5 mM 
MgCl2), and the lysate was centrifuged at 
10,000 × g for 5 min at 4 °C to remove 
insoluble fractions. The supernatant was 
collected as sup B. The secPLAP-HA in the 
mixture of sup A and sup B was recovered 
through incubation (with rotation) with anti-
HA antibody magnetic beads (MBL) for 16 h 
at 4 °C. The beads containing secPLAP-HA 
protein were washed thrice each with 
PBS/Tween-20 and PBS, and the proteins 
were eluted using PBS containing 1 mg/mL 
HA peptide (MBL). To determine relative 
concentrations, proteins were silver-stained 
using a Silver Stain MS Kit (Wako Pure 
Chemicals, Osaka, Japan) after SDS-PAGE, 
and the captured images were analyzed using 
ImageQuant TL (GE Healthcare). 
ICP-MS—Purified secPLAP-HA was 
decomposed with 1.0 mL of nitric acid under 
microwave heating, and the sample solutions 
were then evaporated to dryness on a hot plate 
and re-dissolved in 1% nitric acid for 
elemental analysis by using ICP-MS. The 
signal intensity of zinc was monitored at m/z 
68, with an integration time of 0.1 s. The zinc 
content measurements obtained were 
normalized against protein content. 
Native-PAGE and ALP zymography—Purified 
secPLAP-HA was separated through native-
PAGE by using gradient gels (Invitrogen) 
with 4× native-PAGE sample buffer (40% 
glycerol, 0.4% bromophenol blue, 200 mM 
Tris-HCl, pH 6.8). To perform ALP 
zymography, gels were rinsed in TBS buffer 
for 10 min and then stained with a BCIP-NBP 
Solution Kit (Nacalai Tesque) to visualize 
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ALP activity. 
Statistical analyses—All data are expressed as 
the mean ± SD of triplicate experiments. 
Statistical significance was determined by the 
one-way analysis of variance (ANOVA) 
followed by Tukey's post hoc test (comparison 
for 3 or more groups) or Student’s t test 
(comparison for 2 groups) at p < 0.05 (*) and 
p < 0.01 (**). 
Data availability—All data generated or 
analyzed during this study are included in this 
published article (and its Supporting 
Information file) or are available from the 
corresponding author (Taiho Kambe, Kyoto 
University, E-mail: kambe1@kais.kyoto-
u.ac.jp) upon reasonable request. 
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Table 1. Mutations introduced in ZNT5 and/or ZNT7 in HAP1 cells used in this study. 
Cells Targeted region Mutation 
HAP-Z5-KO* Exon 11 1-bp insertion in ZNT5
HAP-Z7-KO* Exon 2 28-bp deletion in ZNT7
HAP-Z5Z7-DKO* Exon 11 in ZNT5, Exon 2 in ZNT7 2-bp deletion in ZNT5, 28-bp deletion in ZNT7
HAP-Z7-KO(new) Exon 2 165-bp insertion 
HAP-Z5Z7-DKO(new) Exon 11 in ZNT5, Exon 2 in ZNT7 32-bp deletion in ZNT5, 165-bp insertion in ZNT7
*The detailed investigation is shown in Fig. S3.
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Fig. 1. Alteration of expression of ZIPs localized to early secretory pathway does not 
markedly affect Tnap activity. (A). Tnap activity was not substantially altered by the disruption 
of zip9 or zip13 or both genes (zip9-/-zip13-/-). (B). In zinc-deficient cultures (CX), Tnap activity 
was potently suppressed in zip9-/-zip13-/- cells, similarly as in WT cells. N, normal culture. (C). 
Re-expression of ZIP9 or ZIP13 did not notably affect Tnap activity in zip9-/-zip13-/- cells. (D). 
Disruption of metallothionein genes (mt) in zip9-/-zip13-/- cells did not alter Tnap activity. (E). 
Overexpression of WT ZIP7 or ZIP7 phosphoablative mutant (ZIP7S275A/S276A) did not produce a 
large effect on Tnap activity, whereas the expression of the ZIP7 phosphomimetic active mutant 
(ZIP7S275D/S276D) decreased (but did not eliminate) Tnap activity by ~40%. (F). Tnap activity in 
zip9-/-zip13-/- cells or in zip9-/-zip13-/- cells stably expressing ZIP7S275D/S276D mutant was not 
markedly changed by zinc supplementation. In (A), (B), and (D), Tnap activity was measured 
using total cellular proteins. In (A)-(F), all activities are expressed as means ± SD of triplicate 
experiments (n=3). Statistical significance was analyzed by one-way ANOVA followed by 
Tukey's post hoc test in (A)-(C), or by Student’s t test in (E) and (F). *, p < 0.05; **, p < 0.01; 
n.s., not significant. Calnexin (Cnx) was used as the loading control; mb protein, membrane
protein. Each experiment was performed at least thrice, and representative results from
independent experiments are displayed.
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Fig. 2. Minor contribution of ZIP9 and ZIP13 to Tnap activation process, compared with 
ZNT5-ZNT6 heterodimers and ZNT7 homodimers. (A). TNAP activity relative to that in WT 
cells was not changed in zip9-/-zip13-/- cells as compared with the activity in TKO and TKOzip9-
/-zip13-/- cells (upper graph). Tnap activity was measured using total cellular proteins. 
Confirmation of loss of znt5, znt6, znt7, zip9, and zip13 mRNA expression in TKOzip9-/-zip13-/- 
cells (lower panels). (B). Lack of both Zip9 and Zip13 did not impair the restoration of Tnap 
activity mediated by ZNT5-ZNT6 heterodimers or ZNT7 homodimers in TKOzip9-/-zip13-/- cells. 
Cnx was used as the loading control. *, nonspecific band. (C). Comparison of the effects of lack 
of Zip or Znt proteins on Tnap activity in DT40 cells. In (A) and (B), the measured Tnap activity 
is shown as means ± SD of triplicate experiments (n=3). Statistical significance was analyzed 
by Student’s t test in (A), or by one-way ANOVA followed by Tukey's post hoc test in (B). **, p 
< 0.01; n.s., not significant. Each experiment was performed at least thrice, and representative 
results from independent experiments are presented. 
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Fig. 3. Conserved functions of Mtp12-Mtp5, plant ZNT5-ZNT6 orthologs, in Tnap 
activation. (A). Mtp12 and Mtp5 or Mtp12 and svMtp5 form heterodimers. HA-Mtp12 and 
FLAG-Mtp5 or FLAG-svMtp5 were co-immunoprecipitated (IP) with antibodies against FLAG 
and HA tags, respectively, and 10% of each aliquot that was not subject to co-
immunoprecipitation was immunoblotted (input panel). (B). Decreased Tnap activity in TKO 
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cells was restored by co-expression of HA-Mtp12 and FLAG-Mtp5 but not HA-Mtp12 and 
FLAG-svMtp5. (C). Colocalization of Mtp12 and Mtp5 in the Golgi apparatus in DT40 cells 
stably expressing HA-Mtp12 and FLAG-Mtp5. FLAG-Mtp5 was also double-stained with 
GM130 (right column). DAPI staining and merged images are shown. (D). Replacement of 
histidine or aspartic acid with alanine in putative transmembranous zinc-binding site of Mtp12 
(Mtp12H452A and Mtp12D666A) led to a failure in the restoration of Tnap activity. (E). Restoration 
of Tnap activity by co-expression of untagged Mtp12 and Mtp5 was partial as compared with that 
following co-expression of ZNT5 and ZNT6 (ZNT5-ZNT6). In (B) and (D), stable expression of 
HA-Mtp12 or FLAG-Mtp5s was confirmed through immunoblotting. Cnx was used as the loading 
control. In (B), (D), and (E), the measured Tnap activity is shown as means ± SD of triplicate 
experiments (n=3). Statistical significance was analyzed by Student’s t test in (B) and (E), or 
by one-way ANOVA followed by Tukey's post hoc test in (D). **, p < 0.01. Each experiment 
was performed at least thrice, and representative results from independent experiments are 
displayed. 
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Fig. 4. Lack of proper zinc metalation of secPLAP expressed in TKO cells. (A). secPLAP 
activity was markedly decreased but the protein was present in TKO cells. (B). secPLAP activity 
in TKO cells was restored following the expression of ZNT5-ZNT6 heterodimers. (C). PLAP 
activity was drastically decreased in TKO cells in conjunction with a loss of PLAP protein. (D). 
PLAP activity and protein expression in TKO cells were restored following the expression of 
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ZNT5-ZNT6 heterodimers. ZNT5 used in (B) and (D) was N-terminally fused with Halo-tag. (E). 
PLAP protein expression was restored following treatment with inhibitors of lysosomal 
(bafilomycin A1, Baf A1) and proteasomal (MG132) degradation pathways. (F). secPLAP-HA 
activity was markedly decreased but the protein was present in TKO cells. (G). Relative activity 
of purified secPLAP-HA. Lower panel: immunoblot showing the contents of purified secPLAP-
HA protein used to measure activity. (H). Relative zinc content was substantially decreased in 
secPLAP-HA purified from TKO cells as compared with that from WT cells. (I). ALP 
zymography (left) and immunoblotting with native-PAGE (right) failed to reveal the activity and 
protein of secPLAP-HA purified from TKO cells. PLAP or secPLAP activity in all panels is 
expressed as means ± SD of triplicate experiments (n=3). Statistical significance was analyzed 
by Student’s t test in (A)-(D) and (F)-(H). **, p < 0.01. Each experiment was performed at least 
thrice, and representative results from independent experiments are shown. 
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Fig. 5. Concurrent disruption of ZNT5 and ZNT7 is required for decreasing TNAP activity 
in human HAP1 cells. (A). TNAP activity was markedly decreased in HAP1 cells cultured in 
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zinc-deficient medium (CX) for the indicated periods or in CX medium for 12 h and then for 
12 h in medium supplemented with 20 µM ZnSO4. N, normal culture. (B). TNAP activity was 
decreased in HAP1 cells deficient in both ZNT5 and ZNT7 (HAP-Z5Z7-DKO cells) but not ZNT5 
or ZNT7 alone (HAP-Z5-KO and HAP-Z7-KO cells). *, nonspecific band. (C). Same results as in 
(B) were obtained with a different set of KO cells: HAP-Z7-KO(new) and HAP-Z5Z7-DKO(new)
cells. In (A)-(C), TNAP activity was measured using membrane proteins (mb protein), and is
expressed as means ± SD of triplicate experiments. Calreticulin (CALR) and calnexin (CNX)
are shown as loading controls. (D and E). Loss of TNAP cell-surface localization in HAP-Z5Z7-
DKO cells. WT HAP1 and HAP-Z5Z7-DKO cells were subject to immunofluorescence staining
(D) and cell-surface biotinylation assays (E). In (D), DAPI staining and transmitted light images
are also shown. In (E), input refers to aliquots of the biotinylated proteins before avidin capture,
and biotinylation refers to avidin-captured proteins; tubulin and Na+/K+-ATPase: loading controls
for input and biotinylation, respectively. (F). Inhibition of lysosomal (bafilomycin A1, Baf A1, or
NH4Cl) and proteasomal (MG132 or lactacystin) degradation pathways partially restored TNAP
protein in HAP-Z5Z7-DKO cells. (G and H). Impairment of activation of TNAP and PLAP
overexpressed in HAP-Z5Z7-DKO cells. CALR: loading control. In (G), total TNAP activity
(exogenous plus endogenous TNAP activity) is shown. TNAP and PLAP activities are expressed
as means ± SD of triplicate experiments (n=3). Statistical significance was analyzed by one-
way ANOVA followed by Tukey's post hoc test in (A) and (B), or by Student’s t test in (C). *, p
< 0.05; **, p < 0.01; n.s., not significant. Each experiment was performed at least thrice, and
representative results from independent experiments are displayed.
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Fig. 6. Reduced TNAP activity in HAP-Z5Z7-DKO cells is restored by ZNT5 or ZNT7 re-
expression. (A). Restoration of TNAP activity in HAP-Z5Z7-DKO cells by re-expression of 
ZNT5 or ZNT7. (B). TNAP activity in HAP-Z5Z7-DKO cells was also restored by re-expression 
of chicken Znt5 or Znt7 ortholog. *, nonspecific band. (C and D). TNAP cell-surface localization 
following re-expression of ZNT5 or ZNT7 was confirmed in cell-surface biotinylation assays (C) 
and immunofluorescence staining (D) as described in Figs. 5(D) and (E). (E). Zinc 
supplementation for 24 h did not restore TNAP activity in HAP-Z5Z7-DKO cells. *, nonspecific 
band. (F). Expression of zinc-transport-incompetent ZNT5H451A mutant failed to restore TNAP 
activity in HAP-Z5Z7-DKO cells. *, nonspecific band. In (A), (B), (E), and (F), the measured 
TNAP activity is shown as in Fig. 5 and is expressed as means ± SD of triplicate experiments 
(n=3). Statistical significance was analyzed by one-way ANOVA followed by Tukey's post hoc 
test in (A), (B) and (E), or by Student’s t test in (F). **, p < 0.01; n.s., not significant. CALR and 
CNX: loading controls; mb protein, membrane protein. Each experiment was performed at least 
thrice, and representative results from independent experiments are presented. 
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Fig. 7. ZNT5 recruits ZNT6 to Golgi apparatus. (A). ZNT6 expression was similar in WT, 
HAP-Z5-KO, HAP-Z5Z7-DKO, and HAP-Z5Z7-DKO cells stably expressing WT ZNT5 or 
ZNT5H451A. Endogenous ZNT6 was detected with anti-ZNT6 antibody. CNX: loading control. 
(B-D). ZNT6 localization to the Golgi apparatus depends on the expression of ZNT5 but not 
ZNT7. ZNT6 was co-stained with GM130 (B), ZNT5 (C), or ZNT7 (D) in the indicated cells. 
Merged images with DAPI staining are also shown. Each experiment was performed at least thrice, 
and representative results from independent experiments are shown.  
